Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Clinical utility of FDG-PET for the differential diagnosis among the main forms of dementia

Research output: Contribution to journalReviewResearchpeer-review

  1. Assessment of acute bone loading in humans using [18F]NaF PET/MRI

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Feasibility of multi-parametric PET and MRI for prediction of tumour recurrence in patients with glioblastoma

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. A modality-adaptive method for segmenting brain tumors and organs-at-risk in radiation therapy planning

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Hybrid PET/MRI imaging in healthy unsedated newborn infants with quantitative rCBF measurements using 15O-water PET

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Moderate- to high-intensity exercise does not modify cortical β-amyloid in Alzheimer's disease

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Early Postoperative 18F-FET PET/MRI for Pediatric Brain and Spinal Cord Tumors

    Research output: Contribution to journalJournal articleResearchpeer-review

  • EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders
View graph of relations

AIM: To assess the clinical utility of FDG-PET as a diagnostic aid for differentiating Alzheimer's disease (AD; both typical and atypical forms), dementia with Lewy bodies (DLB), frontotemporal lobar degeneration (FTLD), vascular dementia (VaD) and non-degenerative pseudodementia.

METHODS: A comprehensive literature search was conducted using the PICO model to extract evidence from relevant studies. An expert panel then voted on six different diagnostic scenarios using the Delphi method.

RESULTS: The level of empirical study evidence for the use of FDG-PET was considered good for the discrimination of DLB and AD; fair for discriminating FTLD from AD; poor for atypical AD; and lacking for discriminating DLB from FTLD, AD from VaD, and for pseudodementia. Delphi voting led to consensus in all scenarios within two iterations. Panellists supported the use of FDG-PET for all PICOs-including those where study evidence was poor or lacking-based on its negative predictive value and on the assistance it provides when typical patterns of hypometabolism for a given diagnosis are observed.

CONCLUSION: Although there is an overall lack of evidence on which to base strong recommendations, it was generally concluded that FDG-PET has a diagnostic role in all scenarios. Prospective studies targeting diagnostically uncertain patients for assessing the added value of FDG-PET would be highly desirable.

Original languageEnglish
JournalEuropean Journal of Nuclear Medicine and Molecular Imaging
Volume45
Issue number9
Pages (from-to)1509-1525
Number of pages17
ISSN1619-7070
DOIs
Publication statusPublished - Jul 2018

    Research areas

  • Alzheimer Disease, Dementia/diagnostic imaging, Diagnosis, Differential, Fluorodeoxyglucose F18, Humans, Lewy Body Disease, Positron-Emission Tomography, Prospective Studies

ID: 56524690